5 Key Takeaways

• 1

  Successful collaboration in clinical research is essential for patient safety and data integrity, as outlined in FDA Form 1572.

• 2

  Investigators must adhere to protocol requirements, including proper dosing and supervision, to avoid serious violations and FDA warnings.

• 3

  Informed consent processes must be thorough, especially for vulnerable populations, ensuring participants fully understand risks and alternatives.

• 4

  Compliance with investigational new drug (IND) applications is critical, particularly for combination product studies and gene therapies.

• 5

  Ongoing collaboration between research sites and sponsors enhances study quality, from feasibility assessments to final database lock.